SUMICHEM - SUMITOMO CHEMICAL INDIA LIMITED Share Price

Fertilizers & Agrochemicals

₹455.85+0.40(+0.09%)

Market Open as of Dec 16, 2025, 15:30 IST

Valuation
Market Cap	23.96 kCr
Price/Earnings (Trailing)	44.16
Price/Sales (Trailing)	6.95
EV/EBITDA	29.8
Price/Free Cashflow	60.85
MarketCap/EBT	32.91
Enterprise Value	23.94 kCr

Fundamentals
Revenue (TTM)	3.45 kCr
Rev. Growth (Yr)	-5%
Earnings (TTM)	543.07 Cr
Earnings Growth (Yr)	-7.7%

Profitability
Operating Margin	21%
EBT Margin	21%
Return on Equity	16.97%
Return on Assets	12.24%
Free Cashflow Yield	1.64%

Price to Sales Ratio

Latest reported: 7

Revenue (Last 12 mths)

Latest reported: 3.4 kCr

Net Income (Last 12 mths)

Latest reported: 543.1 Cr

Growth & Returns
Price Change 1W	-5.6%
Price Change 1M	-10.2%
Price Change 6M	-4.2%
Price Change 1Y	-14.9%
3Y Cumulative Return	-0.10%
5Y Cumulative Return	11.4%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-392.06 Cr
Cash Flow from Operations (TTM)	452.73 Cr
Cash Flow from Financing (TTM)	-69.08 Cr
Cash & Equivalents	40.88 Cr
Free Cash Flow (TTM)	423.28 Cr
Free Cash Flow/Share (TTM)	8.48

Balance Sheet
Total Assets	4.44 kCr
Total Liabilities	1.24 kCr
Shareholder Equity	3.2 kCr
Current Assets	3.54 kCr
Current Liabilities	1.14 kCr
Net PPE	408.59 Cr
Inventory	613.34 Cr
Goodwill	60.44 Cr

Capital Structure & Leverage
Debt Ratio	0.00
Debt/Equity	0.01
Interest Coverage	98.15
Interest/Cashflow Ops	72.52

Dividend & Shareholder Returns
Dividend/Share (TTM)	1.2
Dividend Yield	0.25%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Pros

Profitability: Very strong Profitability. One year profit margin are 16%.

Size: Market Cap wise it is among the top 20% companies of india.

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Technicals: Bullish SharesGuru indicator.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -10.2% in last 30 days.

Past Returns: Underperforming stock! In past three years, the stock has provided -0.1% return compared to 11.9% by NIFTY 50.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	0.25%
Dividend/Share (TTM)	1.2
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	10.87

Financial Health
Current Ratio	3.12
Debt/Equity	0.01

Technical Indicators
RSI (14d)	22.7
RSI (5d)	18.6
RSI (21d)	22.09
MACD Signal	Sell
Stochastic Oscillator Signal	Buy
Grufity Signal	Buy
RSI Signal	Buy
RSI5 Signal	Buy
RSI21 Signal	Buy
SMA 5 Signal	Sell
SMA 10 Signal	Sell
SMA 20 Signal	Sell
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Earnings Outlook

Last updated:

The management of Sumitomo Chemical India Limited provided a cautiously optimistic outlook for FY25, emphasizing recovery in the agrochemical sector driven by favorable monsoon forecasts and strategic initiatives. Key points include:

Market Recovery: Expect normalization in demand due to improved weather (IMD predicts above-normal rainfall) and stabilization in global agrochemical markets, including LatAm.
Operational Focus: Aim to recover lost FY24 revenue through volume growth (vs. price-led recovery) and demand generation for new products. Margins are expected to remain stable due to procurement efficiencies, cost controls, and disciplined pricing.
New Products: Launched 6 new products (3 herbicides, 1 insecticide, 2 fungicides) in FY24, with plans to scale sales. Additional 3"“4 proprietary products targeting Kharif/Rabi seasons are in the pipeline.
Manufacturing Expansion: Two "Make in India" projects (Bhavnagar, Tarapur) started commercialization; ramp-up expected in FY25. Dahej plant awaits environmental clearance (target: end-2024) for future proprietary products.
Exports: Global recovery slower but progressing; Bhavnagar plant to operate at full capacity (exports), while Tarapur's utilization delayed to FY26 due to global inventory adjustments.
Cost Discipline: Maintained gross margins (41.7% in Q4) via liquidation of high-cost inventory and procurement strategies. Working capital days reduced by 33 through inventory/collection efficiency.
Sustainability & Diversification: Expanding renewable energy adoption and exploring non-agro segments (e.g., IT chemicals, seeds) via parent company collaborations.
Capex: INR 250"“300 crore planned for new projects, funded internally.

The management remains confident in India's growth potential and long-term leadership in agrochemicals, balancing near-term challenges with strategic investments.

Q&A Session

Last updated:

Major Questions and Answers from Sumitomo Chemical India Limited Q4 and FY24 Earnings Call

Question: What guidance can be provided for FY25? Will the company surpass its past peak performance?
Answer: The focus is on increasing product volumes rather than revenue targets due to significant price declines (25"“30% in generics). Recovery depends on monsoon conditions and demand normalization. Gross margins are expected to remain stable barring geopolitical disruptions.
Question: What is Barrix's performance, and what were its FY24 numbers?
Answer: Barrix, acquired in December 2023, contributed ~INR 10"“12 crore in FY24. Growth is expected in FY25 as its eco-friendly pest-control products gain traction.
Question: What drove the sharp Q4 gross margin expansion (41.7%)?
Answer: Improved product mix, liquidation of high-cost inventory by August 2023, procurement of cheaper raw materials, and disciplined cost controls. Margins are sustainable if input prices remain stable.
Question: How are global agrochemical demand and exports performing?
Answer: Domestic recovery is prioritized due to IMD's above-normal monsoon forecast. LatAm markets face weather-related challenges, but stabilization is expected. Exports (20% of revenue) face pricing pressure but show gradual recovery.
Question: Update on capex projects (Bhavnagar, Tarapur, Dahej) and revenue potential.
Answer:
- Bhavnagar: Operating at full capacity for exports.
- Tarapur: Delayed ramp-up due to global inventory glut; full utilization expected by FY26.
- Dahej: Environmental clearance pending; production likely by 2026. Capex (~INR 250"“300 crore) will be funded internally.
Question: Why the delay in new molecule approvals from the parent company?
Answer: Sumitomo Japan is cautious about commoditization risks post-COVID. India remains a strategic manufacturing hub, with proprietary, high-margin products prioritized for Dahej.
Question: Plans to diversify into non-agrochemical segments (e.g., electronics)?
Answer: Preliminary discussions with SCC Japan about IT chemicals and seeds. Skill development and partnerships are under evaluation, but no immediate commitments.
Question: Sustainability of Q4 gross margins (41.7%) in FY25?
Answer: Margins reflect normalized operations post high-cost inventory liquidation. Stability depends on stable input prices and monsoon-driven demand.
Question: Volume vs. price decline breakdown in FY24.
Answer: Domestic generics saw 8"“9% volume decline and 25"“30% price erosion. Specialty products had minimal price drops (~2%) but 8"“9% volume decline.
Question: New product launches and contributions in FY25.
Answer: Three 9(3) proprietary products launched in FY24 (herbicides, insecticides, fungicides). FY25 targets include 8"“10% revenue contribution from new launches, pending regulatory approvals.
Question: Working capital outlook after FY24 improvements.
Answer: Inventory/receivable days reduced by 33 days in FY24. FY25 may see slight loosening to support volume growth but discipline will remain.
Question: Update on renewable energy adoption.
Answer: Targeting 100% green power by FY25-end via solar installations, saving ~INR 4/unit. Capex of ~INR 25 crore allocated.

Share Holdings

Understand SUMITOMO CHEMICAL INDIA ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
Sumitomo Chemical Company Limited	75%
Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver Fund	1.42%
Sumitomo Pharma Taiwan Co., Ltd.	0%
Taoka Chemical India Private Limited	0%
Taoka Chemical Singapore Private Limited	0%
Taoka Advanced Materials (Shanghai) Co., Ltd.	0%
Sumitomo Pharma Trading (Suzhou) Co., Ltd.	0%
The Polyolefin Company (Singapore) Pte. Ltd.	0%
Botanical Resources Australia Pty Ltd. (BRA Group)	0%
Sumitomo Chemical Australia Pty. Ltd.	0%
McLaughlin Gormley King Company	0%
Mycorrhizal Applications, LLC	0%
Sumika Polymers North America LLC	0%
Sumitomo Chemical Advanced Technologies LLC	0%
Sumitomo Chemical America, Inc.	0%
Sumitomo Pharma America, Inc.	0%
Sumitomo Pharma Canada, Inc.	0%
Valent BioSciences LLC	0%
Valent Canada Inc.	0%
Valent De Mexico, S.A. De C.V.	0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
SRF	SRF	85.94 kCr	15.39 kCr	-2.20%	+23.70%	53.12	5.58	-	-
COROMANDEL	Coromandel International	63.41 kCr	29.06 kCr	-6.00%	+24.60%	26.36	2.18	-	-
UPL	UPL	61.93 kCr	48.38 kCr	+7.90%	+29.30%	28.02	1.28	-	-
PIIND	PI Industries	56.9 kCr	8.17 kCr	+4.70%	-18.70%	35.31	6.97	-	-
BAYERCROP	Bayer CropScience	21.32 kCr	6.24 kCr	-4.90%	-29.30%	27.62	3.88	-	-

Category	SUMICHEM	Fertilizers
PE	44.16	30.12
PS	6.95	2.29
Growth	9.3 %	8.9 %

Key Insights

1. SUMICHEM is among the Top 3 Pesticides & Agrochemicals companies by market cap.
2. The company holds a market share of 3.8% in Pesticides & Agrochemicals.
3. The company is growing at an average growth rate of other Pesticides & Agrochemicals companies.

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	10.7%	3,149	2,844	3,511	3,065	2,645	2,425
Other Income	25.3%	120	96	45	27	19	11
Total Income	11.2%	3,269	2,940	3,556	3,091	2,663	2,435
Cost of Materials	13.2%	1,592	1,407	1,857	1,848	1,565	1,287
Purchases of stock-in-trade	12.9%	316	280	267	231	209	191
Employee Expense	14.3%	265	232	218	202	194	179
Finance costs	18.2%	5.86	5.11	5.39	6.17	5.56	5.51
Depreciation and Amortization	6.6%	66	62	52	45	47	41
Other expenses	8.6%	393	362	355	355	308	305
Total Expenses	6.2%	2,588	2,437	2,902	2,516	2,210	2,138
Profit Before exceptional items and Tax	35.3%	680	503	654	576	453	297
Exceptional items before tax	-	0	0	0	0	0	-30.89
Total profit before tax	35.3%	680	503	654	576	453	267
Current tax	37.7%	169	123	167	143	102	75
Deferred tax	-56.2%	4.94	10	-15.37	8.87	6.13	-13.66
Total tax	31.1%	174	133	152	152	108	62
Total profit (loss) for period	36.9%	506	370	502	424	345	205
Other comp. income net of taxes	-42.4%	-0.98	-0.39	2.28	2.38	1.6	-5.11
Total Comprehensive Income	37%	505	369	504	426	347	200
Earnings Per Share, Basic	42.7%	10.13	7.4	10.06	8.49	6.92	4.1
Earnings Per Share, Diluted	-	10.13	0	0	8.49	6.92	4.1

Description	(%) Q/Q	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024
Revenue From Operations	-12%	930	1,057	679	642	988	839
Other Income	0%	39	39	32	31	31	26
Total Income	-11.6%	969	1,096	711	673	1,020	865
Cost of Materials	2.3%	455	445	420	334	453	385
Purchases of stock-in-trade	-37.8%	70	112	73	80	87	76
Employee Expense	-1.4%	70	71	65	68	66	66
Finance costs	86.4%	2.23	1.66	1.66	1.79	1.22	1.19
Depreciation and Amortization	6.7%	17	16	16	19	16	15
Other expenses	0.9%	113	112	88	96	109	100
Total Expenses	-14.5%	731	855	578	557	760	694
Profit Before exceptional items and Tax	-1.2%	238	241	133	116	260	171
Total profit before tax	-1.2%	238	241	133	116	260	171
Current tax	-4.9%	59	62	31	28	66	44
Deferred tax	88.5%	0.93	0.39	2.43	0.83	0.92	0.77
Total tax	-3.3%	60	62	33	29	67	44
Total profit (loss) for period	0%	178	178	100	87	193	127
Other comp. income net of taxes	117.1%	1.4	-1.34	0.04	1.11	-2.51	0.39
Total Comprehensive Income	1.1%	179	177	100	89	190	127
Earnings Per Share, Basic	-0.4%	3.56	3.57	2	1.74	3.85	2.54
Earnings Per Share, Diluted	-	3.56	0	2	0	0	0

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	9.1%	3,090	2,833	3,511	3,064	2,643	2,423
Other Income	24.2%	119	96	45	36	19	11
Total Income	9.6%	3,210	2,929	3,556	3,100	2,662	2,434
Cost of Materials	12.2%	1,574	1,403	1,857	1,848	1,565	1,287
Purchases of stock-in-trade	12.9%	316	280	267	231	208	190
Employee Expense	8.9%	246	226	217	201	193	178
Finance costs	2.7%	4.87	4.77	5.39	6.16	5.56	5.51
Depreciation and Amortization	3.3%	63	61	52	45	47	41
Other expenses	5.3%	380	361	356	354	309	305
Total Expenses	4.6%	2,536	2,425	2,901	2,514	2,208	2,136
Profit Before exceptional items and Tax	34.1%	674	503	655	586	453	298
Exceptional items before tax	-	0	0	0	0	0	-30.89
Total profit before tax	34.1%	674	503	655	586	453	267
Current tax	36.9%	168	123	167	143	102	75
Deferred tax	-74.5%	3.55	11	0.42	8.87	6.13	-13.66
Total tax	28.6%	172	134	168	152	108	62
Total profit (loss) for period	35.8%	502	370	488	434	345	206
Other comp. income net of taxes	-93%	-0.66	0.14	2.03	2.72	1.29	-6.02
Total Comprehensive Income	35.5%	501	370	490	436	347	200
Earnings Per Share, Basic	41.3%	10.06	7.41	10.09	8.69	6.92	4.12
Earnings Per Share, Diluted	41.3%	10.06	7.41	10.09	8.69	6.92	4.12

Description	(%) Q/Q	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024
Revenue From Operations	-12.8%	914	1,048	665	622	971	832
Other Income	0%	39	39	31	31	31	26
Total Income	-12.3%	953	1,087	696	654	1,002	858
Cost of Materials	1.6%	449	442	416	328	447	383
Purchases of stock-in-trade	-37.5%	71	113	73	80	87	76
Employee Expense	-3.1%	64	66	60	63	61	62
Finance costs	125%	1.9	1.4	1.38	1.49	1.02	0.97
Depreciation and Amortization	7.1%	16	15	16	18	15	14
Other expenses	0%	109	109	84	92	106	98
Total Expenses	-15.4%	715	845	564	541	745	685
Profit Before exceptional items and Tax	-1.7%	238	242	132	113	257	173
Total profit before tax	-1.7%	238	242	132	113	257	173
Current tax	-4.9%	59	62	31	28	66	44
Deferred tax	82.5%	0.82	-0.03	2.53	0.26	0.18	0.59
Total tax	-3.3%	60	62	33	28	66	44
Total profit (loss) for period	-1.1%	178	180	98	84	191	128
Other comp. income net of taxes	115.4%	1.35	-1.27	0.26	0.97	-2.4	0.51
Total Comprehensive Income	0%	179	179	99	85	188	129
Earnings Per Share, Basic	-1.5%	3.56	3.6	1.97	1.69	3.82	2.57
Earnings Per Share, Diluted	-	0	0	1.97	0	0	0

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	8.1%	41	38	53	47	51	47
Current investments	139%	1,091	457	545	346	587	239
Loans, current	103%	206	102	172	181	0.7	0.51
Total current financial assets	26.4%	2,781	2,200	2,439	1,963	2,276	1,773
Inventories	-12.9%	613	704	564	610	562	889
Total current assets	17.4%	3,545	3,020	3,114	2,673	2,943	2,788
Property, plant and equipment	-4%	409	426	451	466	450	393
Capital work-in-progress	55.5%	14	9.36	8.51	3.97	23	53
Goodwill	0%	60	60	60	62	28	0
Non-current investments	92.4%	128	67	0.12	0.12	0.12	0.12
Loans, non-current	-48.9%	90	175	106	6.81	0.72	0.65
Total non-current financial assets	-26.6%	282	384	113	14	22	37
Total non-current assets	-5.3%	894	944	728	640	585	581
Total assets	12%	4,439	3,964	3,843	3,313	3,528	3,369
Total non-current financial liabilities	8.6%	102	94	19	19	16	54
Provisions, non-current	-	0	0	36	26	23	0
Total non-current liabilities	8.6%	102	94	79	68	57	54
Borrowings, current	11.1%	21	19	0.42	0.51	0	0
Total current financial liabilities	16.3%	1,030	886	947	737	874	873
Provisions, current	-46.6%	5.28	9.02	9.24	10	8.24	6.31
Current tax liabilities	767.7%	41	5.61	40	0.53	9.22	2.84
Total current liabilities	17.7%	1,136	965	1,046	801	946	933
Total liabilities	16.8%	1,237	1,059	1,126	869	1,002	987
Equity share capital	0%	499	499	499	499	499	499
Non controlling interest	-9.5%	3.66	3.94	3.22	2.98	0	0
Total equity	10.2%	3,201	2,905	2,717	2,445	2,526	2,382
Total equity and liabilities	12%	4,439	3,964	3,843	3,313	3,528	3,369

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	15.2%	39	34	52	46	50	47
Current investments	138.8%	1,085	455	545	346	587	239
Loans, current	103%	206	102	172	181	0.7	0.51
Total current financial assets	26.9%	2,754	2,170	2,413	1,939	2,275	1,773
Inventories	-12.8%	609	698	558	605	562	889
Total current assets	17.5%	3,508	2,985	3,082	2,644	2,942	2,788
Property, plant and equipment	-4.1%	403	420	445	461	450	393
Capital work-in-progress	55.5%	14	9.36	8.51	3.97	23	53
Goodwill	-	0	0	0	0	28	0
Non-current investments	42.1%	207	146	79	79	0.63	0.63
Loans, non-current	-48.9%	90	175	106	6.81	0.72	0.65
Total non-current financial assets	-8.2%	360	392	191	92	23	37
Total non-current assets	-5.5%	893	945	733	644	586	581
Total assets	12%	4,401	3,930	3,814	3,287	3,528	3,369
Total non-current financial liabilities	5.9%	91	86	16	15	16	54
Provisions, non-current	-	0	0	34	25	23	0
Total non-current liabilities	5.9%	91	86	74	63	57	54
Borrowings, current	5.9%	19	18	0	0	0	0
Total current financial liabilities	16.8%	1,017	871	933	723	875	875
Provisions, current	-49.1%	4.87	8.6	8.35	9.57	8.24	6.31
Current tax liabilities	798.9%	41	5.45	40	0.52	9.22	2.84
Total current liabilities	17.9%	1,116	947	1,027	784	946	935
Total liabilities	16.8%	1,206	1,033	1,102	847	1,003	989
Equity share capital	0%	499	499	499	499	499	499
Total equity	10.3%	3,194	2,897	2,713	2,440	2,525	2,380
Total equity and liabilities	12%	4,401	3,930	3,814	3,287	3,528	3,369

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	18.2%	5.86	5.11	5.39	6.17	-	-
Change in inventories	-134.2%	-93.83	278	49	-183.4	-	-
Depreciation	6.6%	66	62	52	45	-	-
Unrealised forex losses/gains	-54%	-0.74	-0.13	-0.13	-3.36	-	-
Adjustments for interest income	39.7%	82	59	25	10	-	-
Net Cashflows from Operations	-30.6%	617	889	557	364	-	-
Income taxes paid (refund)	27.3%	164	129	168	143	-	-
Net Cashflows From Operating Activities	-40.4%	453	760	389	222	-	-
Proceeds from sales of PPE	78.3%	0.87	0.4	0.35	1.06	-	-
Purchase of property, plant and equipment	-56.9%	29	66	120	114	-	-
Proceeds from sales of investment property	-8.3%	1,462	1,594	1,330	597	-	-
Purchase of investment property	-2.6%	1,890	1,941	1,552	780	-	-
Purchase of intangible assets	-182%	0	2.22	0	0	-	-
Purchase of intangible assets under development	-9900%	0	0.99	0	0	-	-
Purchase of goodwill	-101.6%	0	62	0	0	-	-
Interest received	42.2%	65	46	14	5.89	-	-
Net Cashflows From Investing Activities	9.2%	-392.06	-431.72	-327.2	-290.2	-	-
Proceeds from borrowings	-104.1%	0	0.51	0	0	-	-
Repayments of borrowings	-	0.51	0	0	0	-	-
Payments of lease liabilities	-5.3%	19	20	21	21	-	-
Dividends paid	-86.1%	44	310	50	40	-	-
Interest paid	611.5%	4.7	1.52	1.54	1.45	-	-
Other inflows (outflows) of cash	-214.9%	-1.16	2.88	0	0	-	-
Net Cashflows from Financing Activities	78.7%	-69.08	-328.31	-72.54	-62.64	-	-
Net change in cash and cash eq.	-646%	-8.4	-0.26	-10.36	-131.06	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	2.7%	4.87	4.77	5.39	6.16	-	-
Change in inventories	-133.5%	-93.37	283	49	-183.95	-	-
Depreciation	3.3%	63	61	52	45	-	-
Unrealised forex losses/gains	-87%	-0.72	0.08	-0.37	-3.02	-	-
Dividend income	-566.7%	0	0.85	0.15	9.14	-	-
Adjustments for interest income	39.7%	82	59	25	10	-	-
Net Cashflows from Operations	-29.6%	623	885	558	366	-	-
Income taxes paid (refund)	27.3%	164	129	168	143	-	-
Net Cashflows From Operating Activities	-39.3%	459	756	389	223	-	-
Cashflows used in obtaining control of subsidiaries	-101.3%	0	78	0	0	-	-
Proceeds from sales of PPE	72%	0.86	0.5	0.35	1.06	-	-
Purchase of property, plant and equipment	-54.2%	28	60	120	114	-	-
Proceeds from sales of investment property	-9.4%	1,445	1,594	1,330	597	-	-
Purchase of investment property	-2.1%	1,887	1,928	1,552	780	-	-
Purchase of intangible assets	-11.1%	0	0.1	0	0	-	-
Purchase of intangible assets under development	-9900%	0	0.99	0	0	-	-
Dividends received	-566.7%	0	0.85	0.15	9.14	-	-
Interest received	40%	64	46	14	5.89	-	-
Net Cashflows From Investing Activities	5.2%	-403.94	-426	-327.05	-280.81	-	-
Payments of lease liabilities	-15.8%	17	20	21	21	-	-
Dividends paid	-86.1%	44	310	50	40	-	-
Interest paid	691.4%	3.77	1.35	1.54	1.45	-	-
Other inflows (outflows) of cash	-	-1.1	0	0	0	-	-
Net Cashflows from Financing Activities	79.8%	-66.21	-331.18	-72.54	-62.55	-	-
Net change in cash and cash eq.	-514.6%	-11.23	-0.99	-10.18	-120.17	-	-

Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company exports its products. Sumitomo Chemical India Limited was incorporated in 2000 and is headquartered in Mumbai, India. The company is a subsidiary of Sumitomo Chemical Company Limited.

Industry Group:Fertilizers & Agrochemicals

Employees:1,649

Website:www.sumichem.co.in

Important Disclosure & Data Context

This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.

SUMICHEM - SUMITOMO CHEMICAL INDIA LIMITED Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does SUMITOMO CHEMICAL INDIA LIMITED do?

Important Disclosure & Data Context

SUMICHEM - SUMITOMO CHEMICAL INDIA LIMITED Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Sharesguru Stock Score for SUMICHEM

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does SUMITOMO CHEMICAL INDIA LIMITED do?

Important Disclosure & Data Context

Sharesguru Stock Score for SUMICHEM